Article Details

Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 candidate - PR Newswire

Retrieved on: 2022-12-20 11:58:05

Tags for this article:

Click the tags to see associated articles and topics

Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 candidate - PR Newswire. View article details on hiswai:

Excerpt

PRNewswire/ -- As communicated earlier, Eurocine Vaccines is conducting preclinical trials to evaluate the mRNA and protein technology platforms ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up